MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

    MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

    Objective: The aim of our study was to observe the clinical characteristics of different movement disorders (MD) in patients with multiple sclerosis (MS). Background: Demyelinating…
  • 2024 International Congress

    Reliability and Validity of the English Version of the Parkinson Anxiety Scale

    J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…
  • 2024 International Congress

    Pump Priming a Parkinson’s Rapid Response Physiotherapy and Occupational Therapy Service

    F. Lindop, R. Skelly, B. Denney, S. Voyce (Derby, United Kingdom)

    Objective: To establish a Parkinson's (PD) rapid therapy service offering in-reach to wards and outreach into the community. The aim is to improve overall care,…
  • 2024 International Congress

    Revitalizing Lives: The Dystonia Care Rehabilitation Program

    A. Zawar (Lynnwood, USA)

    Objective: The Cervical Dystonia Care Program aims to enhance engagement in task-specific performance, improve quality of life, activity tolerance, and facilitate a return to higher…
  • 2024 International Congress

    Effects of Telerehabilitation on Balance, Gait, Functional Mobility, Physical Activity, Quality of Life, and Social Support Among Adults with Parkinson Disease: A Systematic Review

    P. Darbandsari, L. Pescatello, D. Piscitelli, J. Smith, C. Colon-Semenza (Storrs, USA)

    Objective: This systematic review examined the effect of telerehabilitation on balance, gait, functional mobility, physical activity, quality of life, and social support among adults living…
  • 2024 International Congress

    Impact of Community Boxing Program on Non-motor Symptoms in Individuals with Parkinson’s Disease

    M. Braitsch, S. Shearin, R. Querry, E. Perez (Richardson, USA)

    Objective: The purpose of this intervention was to assess the impact of boxing on non-motor symptoms (NMS) in PD. Background: ​​​​​​For persons with Parkinson’s Disease…
  • 2024 International Congress

    Loneliness Relates to Gait Over Other Features of Parkinsonism

    D. Gonzalez, R. Wilson, M. Tosin, C. Goetz (Chicago, USA)

    Objective: To assess the relationship between loneliness and facets of parkinsonism in community-based samples. Background: Loneliness increases the risk of mortality, dementia, depression, and motor…
  • 2024 International Congress

    Improving Neuropsychiatric Comorbidity in Geriatric Spinocerebellar Ataxia

    M. Le, B. Carr (Gainesville, USA)

    Objective: This study evaluates neuropsychiatric comorbidity in spinocerebellar ataxia (SCA) and highlights key aspects of management in the geriatric population. It discusses efficacy of neuropsychotropic…
  • 2024 International Congress

    eHealth Technologies for People with Parkinson’s: Acceptance & Implications

    J. Stuempel, V. Fleckenstein, J. Hohn, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To investigate the impact of eHealth on Parkinson's care, focusing on technology acceptance and examining ethical, legal, social, and medical aspects of wearables. Background:…
  • 2024 International Congress

    Improvement in Upright Stability subscale of mFARS with Vatiquinone Treatment in MOVE-FA: a Phase 3, Double-blind, Placebo-controlled Trial

    D. Lynch, A. Duquette, M. França Jr, S. Perlman, A. Durr, E. Bertini, A. Darling, K. Mathews, L. Schöls, A. Fournier, M. Delatycki, S. Subramony, R. Roxburgh, O. Zhang, C. Rummey, A. Salvucci, B. Yao, J. Cherry, L. Golden, T. Zesiewicz (Philadelphia, USA)

    Objective: Describe the results of vatiquinone on the Upright Stability Subscale (USS) from MOVE-FA (NCT04577352), the 72-week placebo-controlled phase 3 study of patients with Friedreich…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley